US Stock MarketDetailed Quotes

Corvus Pharmaceuticals (CRVS)

Watchlist
  • 15.970
  • +0.160+1.01%
Close May 12 15:59 ET
  • 16.000
  • +0.030+0.19%
Post 19:59 ET
1.34BMarket Cap-29.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corvus Pharmaceuticals (CRVS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
49.94%14.88M
55.99%42.97M
50.73%12.22M
45.72%10.57M
72.87%10.26M
58.68%9.92M
17.69%27.55M
43.43%8.11M
30.49%7.26M
5.57%5.94M
Selling and administrative expenses
49.94%3.7M
13.34%9.25M
6.90%2.28M
4.18%2.12M
31.08%2.39M
13.36%2.47M
18.63%8.16M
29.00%2.13M
27.46%2.03M
10.10%1.82M
-General and administrative expense
49.94%3.7M
13.34%9.25M
6.90%2.28M
4.18%2.12M
31.08%2.39M
13.36%2.47M
18.63%8.16M
29.00%2.13M
27.46%2.03M
10.10%1.82M
Research and development costs
49.94%11.18M
73.94%33.72M
66.37%9.94M
61.89%8.45M
91.37%7.87M
82.90%7.45M
17.30%19.39M
49.39%5.97M
31.70%5.22M
3.68%4.11M
Operating profit
-49.94%-14.88M
-55.99%-42.97M
-50.73%-12.22M
-45.72%-10.57M
-72.87%-10.26M
-58.68%-9.92M
-17.69%-27.55M
-43.43%-8.11M
-30.49%-7.26M
-5.57%-5.94M
Net non-operating interest income expense
239.81%1.78M
37.34%2.51M
18.70%603K
30.39%738K
47.24%639K
66.14%525K
15.15%1.82M
33.68%508K
33.18%566K
7.69%434K
Non-operating interest income
239.81%1.78M
37.34%2.51M
18.70%603K
30.39%738K
47.24%639K
66.14%525K
15.15%1.82M
33.68%508K
33.18%566K
7.69%434K
Other net income (expense)
-102.44%-599K
168.86%25.18M
84.34%-707K
99.04%-323K
30.99%1.62M
10,319.49%24.59M
-602.44%-36.57M
-226.77%-4.52M
-3,776.07%-33.53M
196.50%1.24M
Gain on sale of security
----
181.32%27.14M
--0
----
10.79%2.01M
--25.13M
---33.38M
---2.35M
---32.85M
--1.82M
Earnings from equity interest
-11.13%-599K
38.76%-1.96M
67.48%-707K
52.64%-323K
32.58%-389K
-328.39%-539K
39.50%-3.2M
-54.84%-2.17M
21.16%-682K
55.06%-577K
Special income (charges)
----
--0
----
----
----
----
--5K
----
----
----
-Gain on sale of property,plant,equipment
----
--0
----
----
----
----
--5K
----
----
----
Income before tax
-190.12%-13.69M
75.47%-15.28M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8M
366.50%15.19M
-130.47%-62.29M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
Income tax
Net income
-190.12%-13.69M
75.47%-15.28M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8M
366.50%15.19M
-130.47%-62.29M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
Net income continuous Operations
-190.12%-13.69M
75.47%-15.28M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8M
366.50%15.19M
-130.47%-62.29M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
Minority interest income
Net income attributable to the parent company
-190.12%-13.69M
75.47%-15.28M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8M
366.50%15.19M
-130.47%-62.29M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-190.12%-13.69M
75.47%-15.28M
-1.72%-12.32M
74.74%-10.16M
-87.66%-8M
366.50%15.19M
-130.47%-62.29M
-82.07%-12.11M
-570.28%-40.22M
34.46%-4.26M
Basic earnings per share
-171.43%-0.15
81.37%-0.19
16.67%-0.15
80.00%-0.12
-42.86%-0.1
275.00%0.21
-82.14%-1.02
-38.46%-0.18
-400.00%-0.6
50.00%-0.07
Diluted earnings per share
-15.38%-0.15
48.04%-0.53
16.67%-0.15
80.00%-0.12
-42.86%-0.1
-8.33%-0.13
-82.14%-1.02
-38.46%-0.18
-400.00%-0.6
50.00%-0.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 49.94%14.88M55.99%42.97M50.73%12.22M45.72%10.57M72.87%10.26M58.68%9.92M17.69%27.55M43.43%8.11M30.49%7.26M5.57%5.94M
Selling and administrative expenses 49.94%3.7M13.34%9.25M6.90%2.28M4.18%2.12M31.08%2.39M13.36%2.47M18.63%8.16M29.00%2.13M27.46%2.03M10.10%1.82M
-General and administrative expense 49.94%3.7M13.34%9.25M6.90%2.28M4.18%2.12M31.08%2.39M13.36%2.47M18.63%8.16M29.00%2.13M27.46%2.03M10.10%1.82M
Research and development costs 49.94%11.18M73.94%33.72M66.37%9.94M61.89%8.45M91.37%7.87M82.90%7.45M17.30%19.39M49.39%5.97M31.70%5.22M3.68%4.11M
Operating profit -49.94%-14.88M-55.99%-42.97M-50.73%-12.22M-45.72%-10.57M-72.87%-10.26M-58.68%-9.92M-17.69%-27.55M-43.43%-8.11M-30.49%-7.26M-5.57%-5.94M
Net non-operating interest income expense 239.81%1.78M37.34%2.51M18.70%603K30.39%738K47.24%639K66.14%525K15.15%1.82M33.68%508K33.18%566K7.69%434K
Non-operating interest income 239.81%1.78M37.34%2.51M18.70%603K30.39%738K47.24%639K66.14%525K15.15%1.82M33.68%508K33.18%566K7.69%434K
Other net income (expense) -102.44%-599K168.86%25.18M84.34%-707K99.04%-323K30.99%1.62M10,319.49%24.59M-602.44%-36.57M-226.77%-4.52M-3,776.07%-33.53M196.50%1.24M
Gain on sale of security ----181.32%27.14M--0----10.79%2.01M--25.13M---33.38M---2.35M---32.85M--1.82M
Earnings from equity interest -11.13%-599K38.76%-1.96M67.48%-707K52.64%-323K32.58%-389K-328.39%-539K39.50%-3.2M-54.84%-2.17M21.16%-682K55.06%-577K
Special income (charges) ------0------------------5K------------
-Gain on sale of property,plant,equipment ------0------------------5K------------
Income before tax -190.12%-13.69M75.47%-15.28M-1.72%-12.32M74.74%-10.16M-87.66%-8M366.50%15.19M-130.47%-62.29M-82.07%-12.11M-570.28%-40.22M34.46%-4.26M
Income tax
Net income -190.12%-13.69M75.47%-15.28M-1.72%-12.32M74.74%-10.16M-87.66%-8M366.50%15.19M-130.47%-62.29M-82.07%-12.11M-570.28%-40.22M34.46%-4.26M
Net income continuous Operations -190.12%-13.69M75.47%-15.28M-1.72%-12.32M74.74%-10.16M-87.66%-8M366.50%15.19M-130.47%-62.29M-82.07%-12.11M-570.28%-40.22M34.46%-4.26M
Minority interest income
Net income attributable to the parent company -190.12%-13.69M75.47%-15.28M-1.72%-12.32M74.74%-10.16M-87.66%-8M366.50%15.19M-130.47%-62.29M-82.07%-12.11M-570.28%-40.22M34.46%-4.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -190.12%-13.69M75.47%-15.28M-1.72%-12.32M74.74%-10.16M-87.66%-8M366.50%15.19M-130.47%-62.29M-82.07%-12.11M-570.28%-40.22M34.46%-4.26M
Basic earnings per share -171.43%-0.1581.37%-0.1916.67%-0.1580.00%-0.12-42.86%-0.1275.00%0.21-82.14%-1.02-38.46%-0.18-400.00%-0.650.00%-0.07
Diluted earnings per share -15.38%-0.1548.04%-0.5316.67%-0.1580.00%-0.12-42.86%-0.1-8.33%-0.13-82.14%-1.02-38.46%-0.18-400.00%-0.650.00%-0.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -